April 24, 2013

BIO Buzz Center with Ken Kelley, CEO, PaxVax

Source: Biotechnology Innovation Organization
Publication Date: April 24, 2013
Visit Source

In an interview with BIO Buzz, Kenneth Kelley, PaxVax CEO, discusses how PaxVax is differentiating itself from other biotechnology companies and vaccine multinational companies as well as the company’s one-dose, oral cholera vaccine in development.